Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
GoodRx Holdings ( (GDRX) ) just unveiled an announcement.
GoodRx Holdings, Inc. has appointed Thomas Chan as its Chief Accounting Officer and principal accounting officer, effective April 23, 2026, elevating him from his prior role as Vice President, Corporate Controller. Chan, 40, joined the company in October 2020 and has held a series of senior controllership and financial reporting positions after nearly a decade in audit and assurance at Deloitte & Touche.
In connection with his promotion, the board set Chan’s annual base salary at $310,000 with a target bonus equal to 40% of salary and approved new restricted stock unit and performance-based stock unit awards valued at $131,250 and $43,750, respectively, with multi-year, employment-contingent vesting schedules. The company noted that Chan has no related-party transactions or family relationships with current or former directors or executives and has entered into its standard indemnification agreement for officers.
The most recent analyst rating on (GDRX) stock is a Sell with a $3.00 price target. To see the full list of analyst forecasts on GoodRx Holdings stock, see the GDRX Stock Forecast page.
Spark’s Take on GDRX Stock
According to Spark, TipRanks’ AI Analyst, GDRX is a Neutral.
The score is driven primarily by improved financial stability (profitability rebound, consistent cash generation, and sharply reduced leverage), partially offset by weak price trends and a transitional earnings outlook where 2026 guidance points to revenue/EBITDA declines and continued pressure in the core prescription transactions business. Valuation is supportive but not strong enough to outweigh near-term growth and momentum risks.
To see Spark’s full report on GDRX stock, click here.
More about GoodRx Holdings
GoodRx Holdings, Inc. operates in the healthcare and digital health industry, providing price comparison tools, discounts, and related services to help consumers save on prescription medications. The company focuses on leveraging technology and data to improve access to affordable drugs across the U.S. pharmacy market, working with consumers, pharmacies, and other healthcare stakeholders.
Average Trading Volume: 2,873,582
Technical Sentiment Signal: Sell
Current Market Cap: $787.9M
See more insights into GDRX stock on TipRanks’ Stock Analysis page.